Literature DB >> 19926774

Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairment.

Robert A Dean1, Leslie M Shaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19926774     DOI： 10.1373/clinchem.2009.134692

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  8 in total

Review 1.  Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Authors:  John Q Trojanowski; Hugo Vandeerstichele; Magdalena Korecka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Z Potter; Michael W Weiner; Clifford R Jack; William Jagust; Arthur W Toga; Virginia M-Y Lee; Leslie M Shaw
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Michal Figurski; Els Coart; Kaj Blennow; Holly Soares; Adam J Simon; Piotr Lewczuk; Robert A Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-02-11       Impact factor: 17.088

Review 3.  The Role of PICALM in Alzheimer's Disease.

Authors:  Wei Xu; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2014-09-04       Impact factor: 5.590

4.  Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.

Authors:  Matthew T White; Leslie M Shaw; Sharon X Xie
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

5.  The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach.

Authors:  Nicolas Ruffini; Susanne Klingenberg; Raoul Heese; Susann Schweiger; Susanne Gerber
Journal:  Front Aging Neurosci       Date:  2022-06-27       Impact factor: 5.702

6.  Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.

Authors:  Meryl S Lillenes; Alberto Rabano; Mari Støen; Tahira Riaz; Dorna Misaghian; Linda Møllersen; Ying Esbensen; Clara-Cecilie Günther; Per Selnes; Vidar T V Stenset; Tormod Fladby; Tone Tønjum
Journal:  Mol Brain       Date:  2016-05-28       Impact factor: 4.041

7.  Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.

Authors:  Kwangsik Nho; Alexandra Kueider-Paisley; Siamak MahmoudianDehkordi; Matthias Arnold; Shannon L Risacher; Gregory Louie; Colette Blach; Rebecca Baillie; Xianlin Han; Gabi Kastenmüller; Wei Jia; Guoxiang Xie; Shahzad Ahmad; Thomas Hankemeier; Cornelia M van Duijn; John Q Trojanowski; Leslie M Shaw; Michael W Weiner; P Murali Doraiswamy; Andrew J Saykin; Rima Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2018-10-15       Impact factor: 16.655

8.  Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population.

Authors:  J A Monge-Argilés; R Gasparini-Berenguer; M Gutierrez-Agulló; C Muñoz-Ruiz; J Sánchez-Payá; C Leiva-Santana
Journal:  Biomed Res Int       Date:  2016-03-22       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.